Recent

% | $
Quotes you view appear here for quick access.

Celgene Corporation Message Board

  • footedoctor footedoctor Feb 6, 1998 5:28 PM Flag

    FDA approval

    Does anyone out there have any idea about when the FDA is going to give its approval for the leprosy drug.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • the fda will approve the drug when the guidelines are established for distribution of the drug; ie..informed consent for the
      patient and physician. the capsules will have a marking on them indicating this drug is not for use by pregnant women. also female
      patients must be on birth control in order to receive this med so more guidelines...so on and so forth so it is a matter of time.
      this should all occur within a few months. i expect any time now. there is much excietment with the approval and lots of
      physicians and clinics will try to use the product as soon as it is released and not just for leprosy but the wasting syndrome of aids
      and cancer. this drug is a great anti-emetic and will alow for weight gain. i have a position and will hold. this company may
      have assets and products that other pharm. companiens may want. think merger or buyout. this is the year for it.

      • 1 Reply to moranicus
      • Considering the fact that this company has such a huge 52 week stock price range (roughly 5 - 13), let's not be overly
        excited about the anticipated FDA approval. If the approvals don't happen or don't happen within the first quarter, I think you may
        see the price fall as larger institutional investors bail out. However, I too have a long position and am betting on good news
        in the near term. Let me pose this question: why are EPS projections so low in 1998? I understand that there are some
        significant (and diverse)markets if Thalidimide is approved. Why don't the analyst projections indicate this? Is is because Thalidimide
        is expensive to manufacture? Your insights...please.

 
CELG
103.41-4.62(-4.28%)Apr 29 4:00 PMEDT